Trading Signals: VNDA Stock Price Prediction and Forecast (Wed. Apr. 12, 2006 - Fri. May. 26, 2023)(Vanda Pharmaceuticals Inc.)
| VNDA latest price $21.4500 (-0.92%) ($21.4500 - $21.9500) on Mon. Aug. 13, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.71% (three month average) | | RSI | 59 | | Latest Price | $21.4500(-0.92%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | VNDA advances 0.1% a day on average for past five trading days. | | Weekly Trend | VNDA advances 3.4% a week on average for past two weeks. | | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support VNDA advance at 0% a week (0% probability)
XBI(48%) IBB(42%) IWO(41%) IWC(39%) IWM(39%) | | Factors Impacting VNDA price | VNDA will decline at least -0.855% in a week (0% probabilities).
VXX(-12%) VIXM(-12%) TLT(-11%) UUP(-7%) GDXJ(-5%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.855% (StdDev 1.71%) | | Hourly BBV | 0 () | | Intraday Trend | -1.4% | | | | | |
|
| 5 Day Moving Average | $21.78(-1.52%) | | 10 Day Moving Average | $21.45(0%) | | 20 Day Moving Average | $21.02(2.05%) | | To recent high | -3.7% | | To recent low | 29.6% | | Market Cap | $1.172b | | | | | | |
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC. |